Our results will be presented at EORTC!

We are happy to present the latest results from our R&D laboratoriries at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics held on 06-09 November in Dublin.  Our communication is entitled: "Discovery of CPL-407-22 - novel, potent and highly selective JAK2 kinase inhibitor."

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+